Immunogenicity and Safety of Homologous and Heterologous Booster Vaccination of ChAdOx1 nCoV-19 (COVISHIELD &lt;sup&gt;TM&lt;/sup&gt;) and BBV152 (COVAXIN®) in Previous Recipients of COVISHIELD &lt;sup&gt;TM&lt;/sup&gt; or COVAXIN®: A Phase 4, Participant and Observer Blinded, Randomised Study

Winsley Rose; Reshma Raju; Sudhir Babji; Anna George; Ramya Madhavan; Julian Vivek Leander Xavier; Jenita Sharon David Chelladurai; Origanti Sharon Nikitha; Arpitha Anbu Deborah; Shalini Vijayakumar; Sushil Immanuel; Jacob John; Priscilla Rupali; Kundavaram Paul Prabhakar Abhilash; Venkata Raghava Mohan; Karthik Bharadwaj Tallapaka; Prasanna Samuel; Gagandeep Kang

Immunogenicity and Safety of Homologous and Heterologous Booster Vaccination of ChAdOx1 nCoV-19 (COVISHIELD <sup>TM</sup>) and BBV152 (COVAXIN®) in Previous Recipients of COVISHIELD <sup>TM</sup> or COVAXIN®: A Phase 4, Participant and Observer Blinded, Randomised Study

SSRN Electronic Journal (2022) - Comments
doi: 10.2139/ssrn.4143699 issn: 1556-5068

Winsley Rose, Reshma Raju, Sudhir Babji, Anna George, Ramya Madhavan, Julian Vivek Leander Xavier, Jenita Sharon David Chelladurai, Origanti Sharon Nikitha, Arpitha Anbu Deborah, Shalini Vijayakumar, Sushil Immanuel, Jacob John, Priscilla Rupali, Kundavaram Paul Prabhakar Abhilash, Venkata Raghava Mohan, Karthik Bharadwaj Tallapaka, Prasanna Samuel, Gagandeep Kang